Abstract
The subjects of this review are the various types of optic nerve disease that involve autoimmune mechanisms, broadly defined. These include optic neuropathy caused by direct inflammatory involvement of the nerve parenchyma and optic nerve damage as an ischemic sequel to primary vasculitis, although there is naturally some overlap between the two conditions. The review considers 1) optic neuropathy that occurs as part of recognized systemic autoimmune disorders and collagen vascular diseases; and 2) isolated autoimmune optic neuropathy in which there is usually some serologic marker indicating the autoimmune nature of the process but without the signs or symptoms of a systemic disease and without the standard criteria for diagnosing a specific systemic disease.
Similar content being viewed by others
References and Recommended Reading
Hsu CT, Kerrison JB, Miller NR, Goldberg MF: Choroidal infarction, anterior ischemic optic neuropathy, and central retinal artery occlusion from polyarteritis nodosa. Retina 2001, 21:348–351.
Jennette JC, Falk RJ: Small-vessel vasculitis. N Engl J Med 1997, 337:1512–1523.
Bakkaloglu A, Ozen S, Baskin E, et al.: The significance of antineutrophil cytoplasmic antibody in microscopic polyangitis and classic polyarteritis nodosa. Arch Dis Child 2001, 85:427–430.
Altaie R, Ditizio F, Fahy GT: Microscopic polyangitis presenting with sub-acute reversible optic neuropathy. Eye 2005, 19:363–365.
Hoffman GS, Kerr GS, Leavitt RY, et al.: Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992, 116:488–498.
Khurma V, Appen R, Wolf MD, Hansen KE: Wegener granulomatosis presenting as bilateral loss of vision. J Clin Rheumatol 2005; 11:267–269.
Monteiro ML, Borges WI, do Val Ferreira RC, et al.: Bilateral optic neuritis in wegener granulomatosis. J Neuroophthalmol 2005, 25:25–28.
Duran E, Merkel PA, Sweet S, et al.: ANCA-associated small vessel vasculitis presenting with ischemic optic neuropathy. Neurology 2004, 62:152–153.
Weinstein JM, Chui H, Lane S, et al.: Churg-Strauss syndrome (allergic granulomatous angiitis). Neuroophthalmologic manifestations. Arch Ophthalmol 1983, 101:1217–1220.
Kattah JC, Chrousos GA, Katz PA, et al.: Anterior ischemic optic neuropathy in Churg-Strauss syndrome. Neurology 1994; 44:2200–2202.
Liou HH, Yip PK, Chang YC, Liu HM: Allergic granulomatosis and angiitis (Churg-Strauss syndrome) presenting as prominent neurologic lesions and optic neuritis. J Rheumatol 1994; 21:2380–2384.
Sehgal M, Swanson JW, DeRemee RA, Colby TV: Neurologic manifestations of Churg-Strauss syndrome. Mayo Clin Proc 1995, 70:337–341.
Vitali C, Genovesi-Ebert F, Romani A, et al.: Ophthalmological and neuro-ophthalmological involvement in Churg-Strauss syndrome: a case report. Graefes Arch Clin Exp Ophthalmol 1996, 234:404–408.
Rosenblatt BJ, Foroozan R, Savino PJ: Asymptomatic optic neuropathy associated with Churg-Strauss syndrome. Ophthalmology 2003, 110:1650–1652.
Hayakawa K, Akatsuka I, Matsukura S, et al.: [Case of anterior isch7emic optic neuropathy accompanied by Churg-Strauss syndrome]. Nippon Ganka Gakkai Zasshi 2004, 108:612–617.
Chuah J, Meaney T: Anterior ischaemic optic neuropathy secondary to Henoch-Schonlein Purpura. Eye 2005, 19:1028.
Wingerchuk DM, Hogancamp WF, O’Brien PC, Weinshenker BG: The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology 1999, 53:1107–1114.
Lucchinetti CF, Mandler RN, McGavern D, et al.: A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Brain 2002, 125Pt 7:1450–1461.
Lennon VA, Wingerchuk DM, Kryzer TJ, et al.: A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004, 364:2106–2112. This is a pivotal development in the diagnosis of neuromyelitis optica as an entity separate from multiple sclerosis.
Mandler RN, Ahmed W, Dencoff JE: Devic’s neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 1998, 51:1219–1220.
Lennon VA, Kryzer TJ, Pittock SJ, et al.: IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005, 202:473–477. This paper provides insight into the mechanisms by which antibody-mediated damage to receptors that regulate water permeability in tissues may underlie the selective vulnerability of that tissue to autoimmune attack.
Hagiwara N, Toyoda K, Uwatoko T, et al.: Successful high dose glucocorticoid treatment for subacute neuromyelitis optica with systemic lupus erythematosus. Intern Med 2005, 44:998–1001.
Delalande S, de SJ, Fauchais AL, et al.: Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients. Medicine (Baltimore) 2004, 83:280–291.
Kadota Y, Tokumaru AM, Kamakura K, et al.: Primary Sjogren’s syndrome initially manifested by optic neuritis: MRI findings. Neuroradiology 2002, 44:338–341.
Dutton JJ, Burde RM, Klingele TG: Autoimmune retrobulbar optic neuritis. Am J Ophthalmol 1982, 94:11–17.
Beck RW, Cleary PA: Optic neuritis treatment trial. Oneyear follow-up results [see comments]. Arch Ophthalmol 1993, 111:773–775.
Kupersmith MJ, Burde RM, Warren FA, et al.: Autoimmune optic neuropathy: evaluation and treatment. J Neurol Neurosurg Psychiatry 1988, 51:1381–1386.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Goodwin, J. Autoimmune optic neuropathy. Curr Neurol Neurosci Rep 6, 396–402 (2006). https://doi.org/10.1007/s11910-996-0020-0
Issue Date:
DOI: https://doi.org/10.1007/s11910-996-0020-0